Overactive Bladder - Results from #1860

Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study - Abstract July 24, 2012

Impact of overactive bladder on work productivity - Abstract July 23, 2012

A survey on the effect of anticholinergic therapy on post-void dribbling - Abstract July 23, 2012

Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS - Abstract July 20, 2012

Quality of life in patients with overactive bladder: Validation and psychometric properties of the spanish overactive bladder questionnaire-short form - Abstract July 19, 2012

A predictive factor in overactive bladder symptoms improvement after combined anterior vaginal wall prolapse repair: a pilot study - Abstract July 18, 2012

Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity - Abstract July 17, 2012

Stand up urgency: Is this symptom related to a urethral mechanism? - Abstract July 16, 2012

What to do if percutaneous tibial nerve stimulation (PTNS) works? A pilot study on home-based transcutaneous tibial nerve stimulation - Abstract July 13, 2012

Changes in urinary nerve growth factor and prostaglandin E(2) in women with overactive bladder after anticholinergics - Abstract July 12, 2012

Antimuscarinic treatment in overactive bladder: Special considerations in elderly patients - Abstract July 11, 2012

Patient-reported goal achievement after antimuscarinic treatment in patients with overactive bladder symptoms - Abstract July 10, 2012

A multicenter, double-blind, randomized, placebo-controlled trial of the β3-Adrenoceptor agonist solabegron for overactive bladder - Abstract July 10, 2012

Treatment of overactive bladder symptoms beyond antimuscarinics: Current and Future Therapies - Abstract July 5, 2012

The association between overactive bladder and fibromyalgia syndrome: A community survey - Abstract July 4, 2012

Efficacy and safety of solifenacin to treat overactive bladder symptoms in patients with idiopathic normal pressure hydrocephalus: An open-label, multicenter, prospective study - Abstract July 3, 2012

Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) survey - Abstract July 2, 2012

FDA approves overactive bladder treatment Myrbetriq™ (mirabegron) from Astellas June 29, 2012

Full prescribing information for MYRBETRIQ™ (mirabegron) extended-release tablets, for oral use, indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency June 29, 2012

FDA approves Myrbetriq for overactive bladder June 29, 2012

Page 94 of 108

SUFU MyBladder app